Vaccine for Omicron Variant , Could Take Months, Says Moderna CEO.<br />CEO of Moderna Stephane Bancel <br />says it could be months before a vaccine targeting the omicron variant of COVID-19 is made available, CNBC reports.<br />CEO of Moderna Stephane Bancel <br />says it could be months before a vaccine targeting the omicron variant of COVID-19 is made available, CNBC reports.<br />Moderna reportedly expects the <br />variant to be highly infectious, <br />but data remains inconclusive.<br />Mutations of the spike protein of the coronavirus have been linked to <br />higher transmission rates.<br />Mutations of the spike protein of the coronavirus have been linked to <br />higher transmission rates.<br />The World Health Organization <br />says the omicron variant has <br />experienced 30 of these mutations.<br />The World Health Organization <br />says the omicron variant has <br />experienced 30 of these mutations.<br />Experts say these mutations could possibly have a negative impact on the efficacy of the coronavirus vaccines.<br />Experts say these mutations could possibly have a negative impact on the efficacy of the coronavirus vaccines.<br />Depending on how much it dropped, we might decide on <br />the one hand to give a higher dose of the current vaccine .., Stephane Bancel, CEO Moderna, via CNBC.<br />Depending on how much it dropped, we might decide on <br />the one hand to give a higher dose of the current vaccine .., Stephane Bancel, CEO Moderna, via CNBC.<br />According to CNBC, Pfizer has started to develop its own vaccine to specifically target the omicron strain.<br />According to CNBC, Pfizer has started to develop its own vaccine to specifically target the omicron strain.<br />Pfizer CEO Albert Bourla says omicrons' impact on COVID-19 vaccines remains unclear.<br />The company reportedly created a DNA template of the new strain on Nov. 26.<br />...we would be <br />able to have the <br />vaccine in less <br />than 100 days, Albert Bourla, CEO Pfizer, via CNBC.<br />...we would be <br />able to have the <br />vaccine in less <br />than 100 days, Albert Bourla, CEO Pfizer, via CNBC
